521 related articles for article (PubMed ID: 31965967)
1. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.
de Montjoye L; Darrigade AS; Giménez-Arnau A; Herman A; Dumoutier L; Baeck M
Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):55-66. PubMed ID: 31965967
[No Abstract] [Full Text] [Related]
2. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
[TBL] [Abstract][Full Text] [Related]
6. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
Magen E; Waitman DA; Kahan NR
Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397
[No Abstract] [Full Text] [Related]
7. Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria.
Kim JH; Lee HY; Ban GY; Shin YS; Park HS; Ye YM
Medicine (Baltimore); 2016 May; 95(19):e3688. PubMed ID: 27175709
[TBL] [Abstract][Full Text] [Related]
8. What Basophil Testing Tells Us About CSU Patients - Results of the CORSA Study.
Marcelino J; Baumann K; Skov PS; Pereira Santos MC; Wyroslak I; Scheffel J; Altrichter S; Woetmann A; Pereira-Barbosa M; Costa C; Maurer M
Front Immunol; 2021; 12():742470. PubMed ID: 34650565
[TBL] [Abstract][Full Text] [Related]
9. Chronic spontaneous urticaria: new evidences on the role of autoimmunity.
Xiang YK; Guloglu S; Elieh-Ali-Komi D; Kocatürk E
Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):438-445. PubMed ID: 37459281
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D
Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
[TBL] [Abstract][Full Text] [Related]
11. The CD63 basophil activation test as a diagnostic tool for assessing autoimmunity in patients with chronic spontaneous urticaria.
HOssein Zadeh Attar M; Merk HF; Kotliar K; Wurpts G; Röseler S; Moll-Slodowy S; Plange J; Baron JM; Balakirski G
Eur J Dermatol; 2019 Dec; 29(6):614-618. PubMed ID: 31903951
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F; González-Aveledo L
Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):5-9. PubMed ID: 29350016
[No Abstract] [Full Text] [Related]
13. Autoimmune Diseases and Low Baseline IgE in Chronic Spontaneous Urticaria: A Clinical and Therapeutic Prospective Analysis in Real-Life Clinical Practice.
Pesqué D; March-Rodríguez Á; Curto-Barredo L; Soto D; Gimeno R; Pujol RM; Giménez-Arnau AM
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3763-3771.e5. PubMed ID: 37716526
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune chronic spontaneous urticaria.
Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
[TBL] [Abstract][Full Text] [Related]
16. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
[TBL] [Abstract][Full Text] [Related]
17. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria.
Yu L; Buttgereit T; Stahl Skov P; Schmetzer O; Scheffel J; Kocatürk E; Zawar V; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1747-1754. PubMed ID: 31025425
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.
Ulambayar B; Chen YH; Ban GY; Lee JH; Jung CG; Yang EM; Park HS; Ye YM
J Microbiol Immunol Infect; 2020 Feb; 53(1):141-147. PubMed ID: 29169972
[TBL] [Abstract][Full Text] [Related]
19. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria.
Asero R; Marzano AV; Ferrucci S; Cugno M
Int Arch Allergy Immunol; 2017; 172(1):40-44. PubMed ID: 28219067
[TBL] [Abstract][Full Text] [Related]
20. Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity.
Chen Q; Zhai Z; Xu J; Chen W; Chen S; Zhong H; Huang X; Hao F; Song Z
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):463-468. PubMed ID: 27518369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
